Table 2.
Comparative study of acute and chronic rejection, graft survival, recurrence, and clinical findings between Group 1 and 2.
| Group 1 with tonsillectomy (n = 9) | Group 2 without tonsillectomy (n = 18) | p-value | |
|---|---|---|---|
| Acute rejection, n (%) | 0 (0) | 3 (16.7) | 0.53 |
| Chronic rejection, n (%) | 1 (11.1) | 6 (33.3) | 0.36 |
| Graft survival, n (%) | 9 (100) | 12 (66.7) | 0.07 |
| Survival, n (%) | 9 (100) | 17 (94.4) | 1.00 |
| Histological recurrence of IgAN, n (%) | 1/9 (11.1) | 10/18 (55.6) | 0.04 |
| Clinical recurrence of IgAN, n (%) | 0/9 (0) | 7/18 (38.9) | 0.06 |
| Serum creatinine (mg/dL)* | 1.55 ± 1.20 | 1.75 ± 0.75 | 0.15 |
| Proteinuria (mg/day)* | 260.9 ± 377.5 | 665.7 ± 822.4 | 0.16 |
| Hematuria (%)* | 0.12 | ||
| Negative or ± 1+ 2+ |
7/7 (100) | 9/15 (60) 4/15 (26.7) 2/15 (13.3) |
IgAN, IgA nephropathy.
*
The data of serum creatinine, proteinuria and hematuria were the 5-year post transplantation data.